The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index; 16 of the 39 sources its claims cite were checked for support.
Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis
Abstract
Objectives: National guidelines for the management of irritable bowel syndrome (IBS) recommend that psychological therapies should be considered, but their relative efficacy is unknown, because there have been few head-to-head trials. We performed a systematic review and network meta-analysis to try to resolve this uncertainty. Design: We searched the medical literature through January 2020 for randomised controlled trials (RCTs) assessing efficacy of psychological therapies for adults with IBS, compared with each other, or a control intervention. Trials reported a dichotomous assessment of symptom status after completion of therapy. We pooled data using a random effects model. Efficacy was reported as a pooled relative risk (RR) of remaining symptomatic, with a 95% CI to summarise efficacy of each comparison tested, and ranked by therapy according to P score. Results: We identified 41 eligible RCTs, containing 4072 participants. After completion of therapy, the psychological interventions with the largest numbers of trials, and patients recruited, demonstrating efficacy included self-administered or minimal contact cognitive behavioural therapy (CBT) (RR 0.61; 95% CI 0.45 to 0.83, P score 0.66), face-to-face CBT (RR 0.62; 95% CI 0.48 to 0.80, P score 0.65) and gut-directed hypnotherapy (RR 0.67; 95% CI 0.49 to 0.91, P score 0.57). After completion of therapy, among trials recruiting only patients with refractory symptoms, group CBT and gut-directed hypnotherapy were more efficacious than either education and/or support or routine care, and CBT via the telephone, contingency management, CBT via the internet and dynamic psychotherapy were all superior to routine care. Risk of bias of trials was high, with evidence of funnel plot asymmetry; the efficacy of psychological therapies is therefore likely to have been overestimated. Conclusions: Several psychological therapies are efficacious for IBS, although none were superior to another. CBT-based interventions and gut-directed hypnotherapy had the largest evidence base and were the most efficacious long term. Trial registration number: The study protocol was published on the PROSPERO international prospective register of systematic reviews (registration number CRD 42020163246).
Overview
CoChat Summary
TL;DR
In a systematic review and network meta-analysis of 41 RCTs including 4072 participants, several psychological therapies were efficacious for IBS, but no active therapy was significantly superior to another. CBT-based interventions and gut-directed hypnotherapy had the largest evidence base and best long-term efficacy, though high risk of bias and possible publication bias suggest efficacy may be overestimated.
Key findings
- Among therapies with the largest evidence base, self-administered or minimal-contact CBT reduced remaining symptomatic (RR 0.61, 95% CI 0.45–0.83, P-score 0.66), face-to-face CBT (RR 0.62, 95% CI 0.48–0.80, P-score 0.65), and gut-directed hypnotherapy (RR 0.67, 95% CI 0.49–0.91, P-score 0.57).
- Contingency management ranked first (RR 0.39, 95% CI 0.19–0.84, P-score 0.89), but this was based on only one small RCT; no psychological therapy was significantly more efficacious than any other active therapy on direct or indirect comparison.
- In 13 RCTs recruiting only patients with refractory IBS, group CBT ranked first (RR 0.05, 95% CI 0.00–0.85, P-score 0.96) but was based on one small RCT; group CBT and gut-directed hypnotherapy were more efficacious than education and/or support or routine care, while telephone CBT, contingency management, internet CBT, and dynamic psychotherapy were superior to routine care.
- All included RCTs were at high risk of bias, and trial-based analysis showed funnel plot asymmetry suggesting publication bias or small-study effects; the paper concludes efficacy of psychological therapies is therefore likely overestimated.
Methods
- Systematic review and network meta-analysis searched MEDLINE, EMBASE, EMBASE Classic, PsychINFO, and Cochrane CENTRAL through January 2020, plus conference proceedings 2001–2019 and recursive bibliography searching.
- Eligible RCTs included adults ≥18 years with IBS, compared psychological therapies with each other or a control intervention, required therapy duration ≥4 weeks and follow-up ≥4 weeks, and reported dichotomous global IBS symptom or abdominal pain response after therapy.
- The analysis included 41 RCTs and 4072 participants (2616 psychological therapy, 1456 control); data were pooled using a frequentist random-effects network meta-analysis in R with netmeta, reporting pooled RR of remaining symptomatic with 95% CI and ranking by P-score.
Limitations
- Stated: trials differed in population, setting, intervention delivery, follow-up duration, and endpoint definition; moderate heterogeneity was observed in the main analysis, and patients were unselected so effects by predominant stool pattern could not be determined.
- Stated: psychological co-morbidity was not routinely screened or examined as a predictor; the variety of interventions meant fewer patients per therapy; most studies were Western, with only one RCT from Japan and one from Israel, limiting generalisability.
- Stated and evident: all RCTs were at high risk of bias due to inability to blind participants, adverse events were poorly reported and could not be meaningfully pooled, and many therapies were supported by only one or two small trials with wide confidence intervals.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
7 Valid · 2 Not valid · 11 Not checked · 91 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“However, for the most part, these are of similar efficacy, and many patients are refractory to medical management.”
What the sources say
- Partly supportedcites [22] sourceExperimental — accuracy not yet measured
The Discussion (page not provided) reports similar numbers needed to treat for two antidepressant classes, TCAs and SSRIs. That supports similarity for those classes, but the paper does not compare licensed and unlicensed IBS drugs generally or classify the treatments by licensing status. (LLM, conf=0.79)
- Partly supportedcites [23] sourceExperimental — accuracy not yet measured
Table 1 reports broadly comparable placebo-controlled results for some IBS drugs, and the Introduction says not all patients respond to treatment. But the monograph does not establish that licensed and unlicensed drugs are, for the most part, similarly effective: it compares treatments with placebo, often in different IBS subtypes, rather than directly with one another. No page numbers are available in our copy. (LLM, conf=0.84)
- Partly supportedcites [24] sourceExperimental — accuracy not yet measured
The Discussion reports that several antispasmodics benefit patients with IBS, which supports the broad point that multiple treatments are effective. It also says evidence is limited for several UK-licensed drugs and that trimebutine showed no benefit over placebo. The paper does not establish that licensed and unlicensed drugs are, for the most part, similarly effective. (LLM, conf=0.83)
- Partly supportedcites [25] sourceExperimental — accuracy not yet measured
The Results report that all studied treatments were more effective than placebo, but the primary analysis found alosetron significantly more effective than every other active treatment except ramosetron 2.5 µg once daily. The Search strategy and study selection section limits the analysis to four licensed drugs for adults with IBS-D or IBS-M; it does not support a general claim about licensed and unlicensed drugs tested across IBS. (LLM, conf=0.85)
- Partly supportedcites [26] Black CJ , Burr NE , Ford AC . Relative efficacy of tegaserod in a systematic review and network meta-analysis of licensed therapies for irritable bowel syndrome with constipation. Clin Gastroenterol Hepatol 2019.doi:10.1016/j.cgh.2019.07.007 sourceExperimental — accuracy not yet measured
The Discussion (p. 7) says that none of the drugs compared was superior to another, and the Results (p. 6) report no significant differences between active treatments. But the paper compares licensed therapies for IBS with constipation; it does not establish similar efficacy across licensed and unlicensed drugs tested in IBS generally. (LLM, conf=0.86)
- Partly supportedcites [27] sourceExperimental — accuracy not yet measured
The Conclusions (p. 7) state that efficacy was similar among the secretagogues and dosages studied for most endpoints. The paper evaluates secretagogues for IBS with constipation, not licensed and unlicensed drugs tested across IBS generally; its comparisons also use 12-week data. (LLM, conf=0.86)
- Disputedcites [28] Ruepert, 2011, Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome, Cochrane Database Syst Rev sourceExperimental — accuracy not yet measured
The Authors’ conclusions (Background; page unavailable) distinguish the treatments: they find no evidence that bulking agents are effective, but evidence that antispasmodics and antidepressants are effective. The Discussion says only that it is unclear whether one antispasmodic is more effective than another; it does not support similar efficacy across IBS drugs generally or compare licensed with unlicensed drugs. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [29] sourceExperimental — accuracy not yet measured
The Results (pp. 18–19) found no significant efficacy differences among the active treatments included in this network meta-analysis. But the analysis covered selected traditional IBS therapies, not licensed and unlicensed IBS drugs generally; the Discussion (p. 25) says a direct efficacy comparison with newer drugs is inappropriate. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Group CBT and CBT via the telephone performed similarly, but based on only two small trials for group CBT, [85, 90] and one trial for CBT via the telephone, [87] although the latter included 558 patients. [87]”
What the sources say
- Not checked — no full text of the sourcecites [85] source
- Not checked — no full text of the sourcecites [90] source
- Partly supportedcites [87] sourceExperimental — accuracy not yet measured
The Results section reports 558 participants in the trial, of whom 186 were assigned to telephone CBT; the Discussion reports that telephone CBT improved outcomes compared with treatment as usual. The paper did not test group CBT or compare its performance with telephone CBT, so it does not support the claimed similarity. The 558 patients were in the trial overall, not the telephone-CBT arm. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although these treatments have effects within the CNS, they also have peripheral effects on pain perception, visceral hypersensitivity, and gastrointestinal motility. [36, 37, 38, 39, 40, 41]”
What the sources say
- Partly supportedcites [36] sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) reports that hypnotherapy can improve abdominal pain and may affect perception of visceral stimuli in IBS. But the Discussion, “Hypnotherapy versus educational therapy” (page unavailable), describes changes in gut motility as a possible consequence of central processes, not a demonstrated peripheral effect. The paper therefore does not establish the claimed peripheral effects on visceral hypersensitivity and gastrointestinal motility. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [37] source
- Not checked — no full text of the sourcecites [38] Lindfors, 2012, Effects on gastrointestinal transit and antroduodenojejunal manometry after gut-directed hypnotherapy in irritable bowel syndrome (IBS), Scand J Gastroenterol source
- Not checked — no full text of the sourcecites [39] source
- Partly supportedcites [40] sourceExperimental — accuracy not yet measured
The Abstract reports that hypnotically induced emotion changed rectal discomfort thresholds in 20 patients with IBS, and describes earlier findings on colonic motility and improved pain. But the Rectal compliance and wall tension section found no change in either measure, while the discussion says the mechanism of altered sensitivity could not be determined. The paper therefore supports effects on gut sensation, but does not establish peripheral effects of psychological and behavioural treatments generally. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Whorwell, 1992, Physiological effects of emotion: assessment via hypnosis, The Lancet source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, the I 2 value can increase with the number of patients included in the meta-analysis. [54]”
What the sources say
- Supportedcites [54] Rücker, 2008, Undue reliance on I 2 in assessing heterogeneity may mislead, BMC Med Res Methodol source
The Background states that I² increases with the number of patients included in the studies in a meta-analysis. The Results also report that I² increased with median study size in an empirical sample of meta-analyses. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In general, the reporting of adverse events in RCTs of psychological interventions has been identified as weak. [105]”
What the sources say
- Supportedcites [105] Duggan, 2014, The recording of adverse events from psychological treatments in clinical trials: evidence from a review of NIHR-funded trials, Trials source
The Discussion states that adverse events were not being adequately reported and says the authors’ examination of 91 NIHR-funded trials confirmed failures to specify, record, and report them during psychological therapy. The Conclusions likewise report that psychological-intervention trials gave adverse-event reporting less attention than trials of other interventions. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
62 more claims · 1 with their cited sources checked
Create a free account to see all 111 claims and every source verdict.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 29
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a meta-analysis of 6 RCTs, recruiting 639 patients, reported a RR of remaining symptomatic of 0.73 (95% CI 0.55 to 0.97) compared with education and/or support and 0.67 (95% CI 0.49 to 0.91) compared with a waiting list control (online supplemental figure 20).156”
From British Society of Gastroenterology guidelines on the management of irritable bowel syndrome (2021) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Face-face CBT (10 RCTs, 930 patients, RR 0.62; 95% CI 0.48 to 0.80)”
From British Society of Gastroenterology guidelines on the management of irritable bowel syndrome (2021) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“group CBT (2 trials, 50 patients, RR 0.41; 95% CI 0.19 to 0.91)”
From British Society of Gastroenterology guidelines on the management of irritable bowel syndrome (2021) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“therapistdelivered CBT over the telephone (1 RCT, 373 patients, RR 0.50; 95% CI 0.29 to 0.84)”
From British Society of Gastroenterology guidelines on the management of irritable bowel syndrome (2021) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, its clinical efficacy has also been demonstrated in non-refractory populations, 156”
From British Society of Gastroenterology guidelines on the management of irritable bowel syndrome (2021) · cites this paper as [156]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269 · cited 1×
“47 Network meta-analysis results usually give a more precise estimate, compared with results from standard, pairwise analyses, 48 49 and can rank treatments to inform clinical decisions.”
Salanti, G., Ades, A. E., & Ioannidis, J. P. A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.016 · Cited by 3,766
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Graphical tools for network meta-analysis in STATA
Chaimani, A., Higgins, J. P. T., Mavridis, D., Spyridonos, P., & Salanti, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076654 · Cited by 2,473
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
Self-citationConsistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
Higgins, J. P. T., Jackson, D., Barrett, J. K., Lu, G., Ades, A. E., & White, I. R. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1044 · Cited by 2,098 · cited 2×
“52 Many meta-analyses use the I 2 statistic to measure heterogeneity, which ranges between 0% and 100%.”
Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction
Drossman, D. A., & Hasler, W. L. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.035 · Cited by 1,928
Ranking treatments in frequentist network meta-analysis works without resampling methods
Rücker, G., & Schwarzer, G. (2015) · BMC Medical Research Methodology · doi:10.1186/s12874-015-0060-8 · Cited by 1,732
Salanti, G. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1037 · Cited by 1,729
Research works printed but not linked: 1
- Lovdahl J , Palsson OS , Ringstrom G , et al . Individual versus group hypnotherapy for IBS: a randomized controlled trial. United European Gastroenterol J;5:A120–1.
Cited by
Oka, P., Parr, H., Barberio, B., Black, C. J., Savarino, E. V., & Ford, A. C. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30217-x · Cited by 882
Self-citationACG Clinical Guideline: Management of Irritable Bowel Syndrome
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001036 · Cited by 893
“They can also include techniques that alter pain perception by activating brain centers that downregulate sensations from the gut and increase psychological flexibility, acceptance, and self-efficacy (245,246).”
BackgroundFord, A. C., Sperber, A. D., Corsetti, M., & Camilleri, M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31548-8 · Cited by 818
Self-citationBritish Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324598 · Cited by 592
“Most were experienced CBT therapists, but some trials used doctoral-level students, and one RCT trained nurses to deliver CBT.”
InfluentialSelf-citationDiagnosis and Treatment of Irritable Bowel Syndrome: A Review
Camilleri, M. (2021) · JAMA · doi:10.1001/jama.2020.22532 · Cited by 362
Metadata
- Authors
- Black, C. J., Thakur, E. R., Houghton, L. A., Quigley, E. M. M., Moayyedi, P., & Ford, A. C.
- Affiliations
- University of Leeds (GB)
- Baylor College of Medicine (US)
- Houston Methodist (US)
- McMaster University (CA)
- Corresponding author
- Ford, Alexander C
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2020-04-10
- Volume
- 69
- Issue
- 8
- Pages
- 1441-1451
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W3015692518
- Cited by
- 299
- References
- 106
- Citations by year
- 2026: 42 · 2025: 63 · 2024: 59 · 2023: 43 · 2022: 44 · 2021: 32 · 2020: 13
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- irritable bowel syndrome, psychotherapy, cognitive behavioral therapy, gut-directed hypnotherapy, contingency management, psychodynamic psychotherapy, symptom remission, treatment efficacy comparison, risk of bias
- MeSH terms
- Humans, Hypnosis, Cognitive Behavioral Therapy, Randomized Controlled Trials as Topic, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. https://app.cochat.ai/papers/10.1136/gutjnl-2020-321191
- The paper
- Black, C. J., Thakur, E. R., Houghton, L. A., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2020). Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut. https://doi.org/10.1136/gutjnl-2020-321191
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.